Informations générales (source: ClinicalTrials.gov)
Évaluation de l'Impact du Compressed Sensing Sur le Signal QSM (CS-QSM)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
décembre 2021
avril 2025
29 juin 2024
Patients who have agreed to participate in the study will complete the MRI protocol as
part of routine care, to which a maximum of four additional 25-minute sequences will be
added.
MRI of routine care includes at least the following sequences:
- 3D T1 TFE (2 minutes)
- T2 TSE (2 minutes)
- 3D FLAIR (3 minutes)
The sequences added by the research lasting 25 minutes are:
- SWI QSM 1.0iso 8 echoes (10 minutes)
- SWI QSM 1.0iso 8 echoes CS 6 (7 minutes)
- SWI QSM 1.0iso 8 echoes CS 9 (5 minutes)
- SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL FONDATION A. DE ROTHSCHILD | Julien SAVATOVSKY | 21/06/2024 13:34:02 | Contacter | ||
Critères
Tous
Inclusion Criteria:
For patients with MS:
- Patient over 18 years old
- Presenting MS defined according to McDonald's revised criteria for spatial and
temporal clinical or radiological dissemination [16],
- Should benefit as part of the care of an MRI examination with or without injection
of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
For patients with an indication to undergo a brain MRI and at low risk of inflammatory
CNS disease:
- Patient over 18 years old
- Should benefit as part of the care of an MRI examination with or without injection
of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
For patients with MS:
- Patient over 18 years old
- Presenting MS defined according to McDonald's revised criteria for spatial and
temporal clinical or radiological dissemination [16],
- Should benefit as part of the care of an MRI examination with or without injection
of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
For patients with an indication to undergo a brain MRI and at low risk of inflammatory
CNS disease:
- Patient over 18 years old
- Should benefit as part of the care of an MRI examination with or without injection
of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
- For patients with MS:
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
For patients with an indication to undergo a brain MRI and at low risk of inflammatory
CNS disease:
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
- Patient with inflammatory and / or demyelinating pathology of the CNS
Secondary exclusion criteria :
- Motion artefact not allowing interpretation of images
- Patient who did not perform one of the following sequences: 3D T1 TFE, 3D FLAIR (for
MS patients), SWI QSM 1.0iso 8 echoes.
Secondarily excluded patients will be replaced.